Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
22
VTRLY Quote, Financials, Valuation and Earnings
Last price:
$15.50
Seasonality move
:
1.61%
Day range:
$15.50 - $15.50
52-week range:
$14.62 - $21.03
Dividend yield:
0.74%
P/E ratio:
48.48x
P/S ratio:
6.07x
P/B ratio:
1.48x
Volume:
--
Avg. volume:
9
1-year change:
-18.85%
Market cap:
$2.1B
Revenue:
$341.3M
EPS (TTM):
$0.32
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Vitrolife AB has -- downside to fair value with a price target of -- per share.
VTRLY vs. S&P 500
-
Over the past 5 trading days, Vitrolife AB has underperformed the S&P 500 by -16.7% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Vitrolife AB does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Vitrolife AB has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Vitrolife AB reported revenues of $87.7M.
Earnings Growth
-
Vitrolife AB earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Vitrolife AB reported earnings per share of $0.08.
Enterprise value:
2.2B
EV / Invested capital:
--
Price / LTM sales:
6.07x
EV / EBIT:
33.06x
EV / Revenue:
6.35x
PEG ratio (5yr expected):
--
EV / Free cash flow:
59.88x
Price / Operating cash flow:
57.31x
Enterprise value / EBITDA:
20.07x
Gross Profit (TTM):
$178M
Return On Assets:
2.56%
Net Income Margin (TTM):
12.53%
Return On Equity:
3.26%
Return On Invested Capital:
2.83%
Operating Margin:
18.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $325.8M | $336.9M | $345.7M | $83.2M | $87.7M | |
| Gross Profit | $181.3M | $171.7M | $178M | $42.4M | $44.8M | |
| Operating Income | $69.6M | $74.2M | $66.4M | $18.2M | $16.3M | |
| EBITDA | $109.3M | $115.7M | $109.3M | $29.3M | $27.8M | |
| Diluted EPS | $0.28 | -$2.63 | $0.32 | $0.08 | $0.08 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $600.4M | $126.9M | $168M | $208.2M | $245.6M | |
| Total Assets | $701.9M | $1.8B | $1.9B | $1.7B | $1.8B | |
| Current Liabilities | $28.1M | $60.4M | $54.9M | $71.4M | $55.8M | |
| Total Liabilities | $41.7M | $342.8M | $345M | $369.5M | $377.9M | |
| Total Equity | $660.2M | $1.5B | $1.6B | $1.3B | $1.4B | |
| Total Debt | $7.8M | $183.7M | $188.4M | $191.1M | $212.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $70.1M | $76.3M | $74M | $19.5M | $26.5M | |
| Cash From Investing | -$10M | -$31.6M | -$30.4M | -$4.4M | -$6.4M | |
| Cash From Financing | -$29.5M | -$25.5M | -$20.8M | -$6.7M | $61.3K | |
| Free Cash Flow | $61M | $56.7M | $36.6M | $15.2M | $20.4M | |
VTRLY
Sector
Market Cap
$2.1B
--
Price % of 52-Week High
73.69%
--
Dividend Yield
0.74%
--
Shareholder Yield
0.61%
--
1-Year Price Total Return
-18.85%
--
Beta (5-Year)
1.353
--
Dividend yield:
0.74%
Annualized payout:
$0.09
Payout ratio:
-33.82%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$16.64
200-day SMA
Sell
Level
$16.35
Bollinger Bands (100)
Sell
Level
14.38 - 17.34
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$17.79
Relative Strength Index (RSI14)
Sell
Level
16.75
ADX Line
Sell
Level
30.96
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$16.74
MACD (12, 26)
Buy
Level
2.97
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Sell
Level
-150
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.6941)
Buy
CA Score
(Annual)
Level (1.102)
Buy
Beneish M-Score
(Annual)
Level (-2.4732)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-6.3469)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Vitrolife AB develops, produces, and markets products for creating, prolonging, and improving life. It focuses on fertility treatments, cell therapy and tissue engineering, and organ transplantation systems. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
Stock Forecast FAQ
In the current month, VTRLY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The VTRLY average analyst price target in the past 3 months is --.
-
Where Will Vitrolife AB Stock Be In 1 Year?
According to analysts, the consensus estimate is that Vitrolife AB share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Vitrolife AB?
Analysts are divided on their view about Vitrolife AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Vitrolife AB is a Sell and believe this share price will rise from its current level to --.
-
What Is Vitrolife AB's Price Target?
The price target for Vitrolife AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is VTRLY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Vitrolife AB is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of VTRLY?
You can purchase shares of Vitrolife AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Vitrolife AB shares.
-
What Is The Vitrolife AB Share Price Today?
Vitrolife AB was last trading at $15.50 per share. This represents the most recent stock quote for Vitrolife AB. Yesterday, Vitrolife AB closed at $15.50 per share.
-
How To Buy Vitrolife AB Stock Online?
In order to purchase Vitrolife AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get VTRLY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VTRLY
Sector
P/E ratio
48.48x
--
PEG ratio
--
--
P/B ratio
1.48x
--
Price / LTM sales
6.07x
--
Growth Metrics
VTRLY
Sector
Revenue growth
5.47%
--
Earnings growth
-3.65%
--
Revenue (5-year growth)
16.89%
--
Earnings forecast
--
--
Profitability
VTRLY
Sector
Profitability FY 2024
$177.4M
--
Return on invested capital
2.83%
--
Return on assets
2.56%
--
Return on equity
3.26%
--
Earnings Date
Last Earnings Date
Oct
23
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Jan
22
Balance Sheet
VTRLY
Sector
Total cash
$117.9M
--
Short term investments
--
--
Total assets
$1.6B
--
Long term debt
$212.9M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
